AR054370A1 - Composiciones de vacunas y procedimientos para ael tratamiento de la incontinencia urinaria - Google Patents

Composiciones de vacunas y procedimientos para ael tratamiento de la incontinencia urinaria

Info

Publication number
AR054370A1
AR054370A1 ARP060102239A ARP060102239A AR054370A1 AR 054370 A1 AR054370 A1 AR 054370A1 AR P060102239 A ARP060102239 A AR P060102239A AR P060102239 A ARP060102239 A AR P060102239A AR 054370 A1 AR054370 A1 AR 054370A1
Authority
AR
Argentina
Prior art keywords
urinary incontinence
treatment
procedures
compositions
vaccine
Prior art date
Application number
ARP060102239A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR054370A1 publication Critical patent/AR054370A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ARP060102239A 2005-06-01 2006-05-30 Composiciones de vacunas y procedimientos para ael tratamiento de la incontinencia urinaria AR054370A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68678905P 2005-06-01 2005-06-01

Publications (1)

Publication Number Publication Date
AR054370A1 true AR054370A1 (es) 2007-06-20

Family

ID=37072557

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102239A AR054370A1 (es) 2005-06-01 2006-05-30 Composiciones de vacunas y procedimientos para ael tratamiento de la incontinencia urinaria

Country Status (15)

Country Link
EP (1) EP1890725A2 (zh)
JP (2) JP2008545738A (zh)
KR (1) KR20080007648A (zh)
CN (1) CN101189026A (zh)
AR (1) AR054370A1 (zh)
AU (1) AU2006253914A1 (zh)
BR (1) BRPI0611390A2 (zh)
CA (1) CA2609244A1 (zh)
MX (1) MX2007015151A (zh)
NO (1) NO20075923L (zh)
RU (1) RU2007143992A (zh)
TW (1) TW200716164A (zh)
UY (1) UY29574A1 (zh)
WO (1) WO2006129162A2 (zh)
ZA (1) ZA200710213B (zh)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2161445C (en) * 1993-04-27 2009-06-30 Anna Efim Ladd Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
AUPP807399A0 (en) * 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
EP1147212B1 (en) * 1999-02-05 2009-08-26 The University Of Melbourne T helper cell epitopes
AU2001295359A1 (en) * 2000-10-30 2002-05-15 University Of Zurich GnRH analogues for treatment of urinary incontinence
US20030144203A1 (en) * 2001-12-19 2003-07-31 Voyager Pharmaceutical Corporation Methods for slowing senescence and treating and preventing diseases associated with senescence

Also Published As

Publication number Publication date
BRPI0611390A2 (pt) 2010-09-08
AU2006253914A1 (en) 2006-12-07
JP2009137972A (ja) 2009-06-25
NO20075923L (no) 2007-12-18
EP1890725A2 (en) 2008-02-27
CN101189026A (zh) 2008-05-28
ZA200710213B (en) 2008-09-25
CA2609244A1 (en) 2006-12-07
WO2006129162A3 (en) 2007-02-08
KR20080007648A (ko) 2008-01-22
WO2006129162A2 (en) 2006-12-07
RU2007143992A (ru) 2009-07-20
UY29574A1 (es) 2006-12-29
TW200716164A (en) 2007-05-01
MX2007015151A (es) 2008-02-15
JP2008545738A (ja) 2008-12-18

Similar Documents

Publication Publication Date Title
BR112013002640A2 (pt) unidade de manipulação com sequência de implante forçada e mecanismo de acionamento independente
ES2524458T3 (es) DNasa para el tratamiento de la subfertilidad masculina
BRPI0712194A2 (pt) Implantes pélvico e cirúrgico combinação ferramenta cirúrgica útil para implantar um implante pélvico métodos de tratamento de uma condição pélvica, e de prolapso vaginal, e, método para manipular um implante cirúrgico
BRPI0717845A2 (pt) Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos
AR037220A1 (es) Extractor de implante oftalmico de doble accion
AR052774A1 (es) Inmunoterapia para trastornos autoinmunes
BRPI0718523B8 (pt) Forma de dosagem, e, método para preparar a forma de dosagem
BRPI0411013A (pt) implante para uso na fusão de estruturas ósseas adjacentes, método de tratar um organismo para promover fusão de estruturas ósseas adjacentes e sistema para uso na fusão de estruturas ósseas adjacentes
WO2007089864A3 (en) Sutures and fibrosing agents
ES2422556T3 (es) Tratamiento de hepatitis vírica
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
BRPI0817482B8 (pt) uso de um anticorpo do receptor da interleucina-6 (il-6) no tratamento da doença do enxerto versus hospedeiro (gvhd)
BRPI0514103A (pt) dispostivo de distribuição
ECSP109852A (es) Uso de homo y copolímeros para la estabilización de formulaciones de principios activos
BRPI0506305A (pt) artigos e métodos de tratamento da pele
CL2007001698A1 (es) Composicion inmunogenica que comprende los lipooligosacaridos meningococicos (los) de inmunotipos l2 y l3 de cepas neissericas; composicion de vacuna que la comprende; procedimiento de preparacion; y su uso para la prevencion o tratamiento de enfermedades causadas por uno o mas serogrupos de n. meningitidis.
AR064725A1 (es) Profilaxis y tratamiento del complejo respiratorio porcino (prdc). uso
CR7330A (es) Procedimiento para tratar enfermedades neovasculares oculares
BR0313672A (pt) Montagem para uso na construção de uma alça compósita para tratar incontinência de um paciente, ferramenta para montagem de alça, kit cirúrgico para uso na montagem de um implante para tratar incontinência, e, métodos cirúrgicos para tratar incontinência e um distúrbio do assoalho pélvico
AR028512A1 (es) Composiciones antimicrobianas acidas para el tratamiento de alimentos y superficies que contactan alimentos y metodos para la utilizacion de estas
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
BRPI0608690B8 (pt) uso de uma composição antimicrobiana
PA8537501A1 (es) Naftostirilos
AR047728A1 (es) Adyuvante antimicrobiano y uso de agentes antimicrobianos como adyuvante de vacunas
AR065319A1 (es) Prevencion y tratamiento de pcvd subclinica

Legal Events

Date Code Title Description
FB Suspension of granting procedure